• A national monoclonal antibody-generating resource funded by NIH

• Generates novel monoclonal antibodies (NeuroMabs) for neuroscience and other fields of basic biomedical research

• NeuroMabs are validated for biochemical and immunohistochemical applications in mammalian brain
  

• Provides low cost, high quality mouse monoclonal antibodies to the research community

• Many ongoing projects (see current projects page), check back frequently for new NeuroMabs

• See suggestion page for details on how to suggest a future NeuroMab project

• Subscribe to our mailing list to receive notifications when new NeuroMabs are added to our catalog

The UC Davis/NIH NeuroMab Facility is a cooperative venture among the University of California at Davis, the National Institute for Neurological Disorders and Stroke, the National Institute for Mental Health, the NIH Blueprint for Neuroscience Research, the NIH Roadmap for Medical Research, the NIH Office of Rare Diseases Research, and Antibodies Incorporated.


For recent review articles on issues of antibody quality in biomedical research that are directly relevant to our mission see Saper, 2005; Rhodes & Trimmer, 2006; Couchman, 2009; and Bordeaux et al., 2010.

Please cite the "UC Davis/NIH NeuroMab Facility" as the source of NeuroMabs. Also, please include the complete clone number (e.g., N52A/42) to avoid ambiguity.

Note that our catalog has the most up-to-date information on new NeuroMabs, including Production and QC status and newly released catalog #'s.

Place orders for NeuroMabs through our distributor Antibodies Incorporated

            Tel:(800) 824-8540 or (530) 758-4400          FAX: (530) 758-6307

Note that a signed MTA is no longer needed to obtain NeuroMabs.  A Research License Agreement will now be included in all shipments.